MBL | MEDICAL & BIOLOGICAL LABORATORIES CO., LTD

New Products

Nov 05, 2018	Anti-human MELK monoclonal antibody is now available. For immunostaining of cancer tissues.
Oct 19, 2018	Human Fibulin-3 and FABP4 ELISA kits were also launched in CircuLex brand! For evaluation of biomarkers for various cancer, metabolism, and inflammation.
Oct 15, 2018	S100B ELISA and S100G ELISA newly joined in CircuLex S100 ELISA series! S100B and S100G are considered as useful biomarkers for neurologic disorders and brain damage.

Nov 05, 2018

For immunostaining of cancer tissues.

Oct 19, 2018

For evaluation of biomarkers for various cancer, metabolism, and inflammation.

Oct 15, 2018

S100B and S100G are considered as useful biomarkers for neurologic disorders and brain damage.

View All

May 22, 2017	Collaboration with A*STAR’s p53 Laboratory to establish the novel drug screening technology facilitating the “undruggable” PPI targets to “druggable”. 90KB
Feb 28, 2017	MEDICAL & BIOLOGICAL LABORATORIES Co., Ltd. concludes a patent licensing agreement with the University of Toyama concerning a rapid antibody production technique 30KB
Jan 27, 2015	Medical and Biological Laboratories Co., Ltd., establishes MBL Europe 56KB

May 22, 2017